BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cloud AS, Vargheese AM, Gunewardena S, Shimak RM, Ganeshkumar S, Kumaraswamy E, Jensen RA, Chennathukuzhi VM. Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression. BMC Cancer 2022;22:180. [PMID: 35177031 DOI: 10.1186/s12885-022-09280-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vcelkova T, Reiter W, Zylka M, Hollenstein DM, Schuckert S, Hartl M, Seiser C. GSE1 links the HDAC1/CoREST co-repressor complex to DNA damage.. [DOI: 10.1101/2023.03.13.532402] [Reference Citation Analysis]
2 Wang G, Yang X, Qi M, Li M, Dong M, Xu R, Zhang C. Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma. Sci Rep 2023;13:3023. [PMID: 36810892 DOI: 10.1038/s41598-023-30248-0] [Reference Citation Analysis]
3 Cloud AS, Koohestani F, McWilliams MM, Ganeshkumar S, Gunewardena S, Graham A, Nothnick WB, Chennathukuzhi VM. Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis. Proc Natl Acad Sci U S A 2022;119:e2205524119. [PMID: 36282915 DOI: 10.1073/pnas.2205524119] [Reference Citation Analysis]
4 Cloud AS, Koohestani F, Mcwilliams MM, Ganeshkumar S, Gunewardena S, Graham A, Nothnick WB, Chennathukuzhi VM. Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis.. [DOI: 10.1101/2022.04.11.487902] [Reference Citation Analysis]